REGENXBIO
RGNX
#7519
Rank
โ‚ฌ0.43 B
Marketcap
6,53ย โ‚ฌ
Share price
-0.28%
Change (1 day)
-36.30%
Change (1 year)

EPS for REGENXBIO (RGNX)

EPS in 2026 (TTM): -2,76ย โ‚ฌ

According to REGENXBIO's latest financial reports the company's current EPS (TTM) is -2,93ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,43ย โ‚ฌ an increase over its 2024 EPS that were of -4,20ย โ‚ฌ.

EPS history for REGENXBIO from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,76ย โ‚ฌ-19.38%
2025-3,43ย โ‚ฌ-18.44%
2024-4,20ย โ‚ฌ
2022-5,93ย โ‚ฌ-321.09%
20212,68ย โ‚ฌ-198.33%
2020-2,73ย โ‚ฌ15.44%
2019-2,36ย โ‚ฌ-181.19%
20182,91ย โ‚ฌ-229.15%
2017-2,25ย โ‚ฌ3.35%
2016-2,18ย โ‚ฌ5.42%
2015-2,07ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ-57.94%๐Ÿ‡บ๐Ÿ‡ธ USA